Table of Content

1 Report Overview
1.1 Bovine Vaccines Definition
1.2 Market by Type
1.2.1 Global Bovine Vaccines Market Size Growth Rate by Type, 2018 VS 2022 VS 2034
1.2.2 Anti Rinderpest Serum
1.2.3 FMD Vaccine
1.2.4 Other
1.3 Market Segment by Application
1.3.1 Global Bovine Vaccines Market Size Growth Rate by Application, 2018 VS 2022 VS 2034
1.3.2 Farm
1.3.3 Government
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Bovine Vaccines Sales
2.1 Global Bovine Vaccines Revenue Estimates and Forecasts 2018-2034
2.2 Global Bovine Vaccines Revenue by Region: 2018 VS 2022 VS 2034
2.3 Global Bovine Vaccines Revenue by Region
2.3.1 Global Bovine Vaccines Revenue by Region (2018-2024)
2.3.2 Global Bovine Vaccines Revenue by Region (2024-2034)
2.4 Global Bovine Vaccines Sales Quantity Estimates and Forecasts 2018-2034
2.5 Global Bovine Vaccines Sales Quantity by Region: 2018 VS 2022 VS 2034
2.6 Global Bovine Vaccines Sales Quantity by Region
2.6.1 Global Bovine Vaccines Sales Quantity by Region (2018-2024)
2.6.2 Global Bovine Vaccines Sales Quantity by Region (2024-2034)
2.7 North America
2.8 Europe
2.9 China
2.10 APAC (excluding China)
2.11 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global Bovine Vaccines Sales Quantity by Manufacturers
3.1.1 Global Bovine Vaccines Sales Quantity by Manufacturers (2018-2024)
3.1.2 Global Bovine Vaccines Sales Quantity Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Companies by Bovine Vaccines Sales in 2022
3.2 Global Bovine Vaccines Revenue by Manufacturers
3.2.1 Global Bovine Vaccines Revenue by Manufacturers (2018-2024)
3.2.2 Global Bovine Vaccines Revenue Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Bovine Vaccines Revenue in 2022
3.3 Global Bovine Vaccines Sales Price by Manufacturers
3.4 Global Key Players of Bovine Vaccines, Industry Ranking, 2021 VS 2022
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Bovine Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Bovine Vaccines, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Bovine Vaccines, Product Offered and Application
3.8 Global Key Manufacturers of Bovine Vaccines, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Estimates and Forecasts by Type
4.1 Global Bovine Vaccines Sales Quantity by Type
4.1.1 Global Bovine Vaccines Historical Sales Quantity by Type (2018-2024)
4.1.2 Global Bovine Vaccines Forecasted Sales Quantity by Type (2024-2034)
4.1.3 Global Bovine Vaccines Sales Quantity Market Share by Type (2018-2034)
4.2 Global Bovine Vaccines Revenue by Type
4.2.1 Global Bovine Vaccines Historical Revenue by Type (2018-2024)
4.2.2 Global Bovine Vaccines Forecasted Revenue by Type (2024-2034)
4.2.3 Global Bovine Vaccines Revenue Market Share by Type (2018-2034)
4.3 Global Bovine Vaccines Price by Type
4.3.1 Global Bovine Vaccines Price by Type (2018-2024)
4.3.2 Global Bovine Vaccines Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global Bovine Vaccines Sales Quantity by Application
5.1.1 Global Bovine Vaccines Historical Sales Quantity by Application (2018-2024)
5.1.2 Global Bovine Vaccines Forecasted Sales Quantity by Application (2024-2034)
5.1.3 Global Bovine Vaccines Sales Quantity Market Share by Application (2018-2034)
5.2 Global Bovine Vaccines Revenue by Application
5.2.1 Global Bovine Vaccines Historical Revenue by Application (2018-2024)
5.2.2 Global Bovine Vaccines Forecasted Revenue by Application (2024-2034)
5.2.3 Global Bovine Vaccines Revenue Market Share by Application (2018-2034)
5.3 Global Bovine Vaccines Price by Application
5.3.1 Global Bovine Vaccines Price by Application (2018-2024)
5.3.2 Global Bovine Vaccines Price Forecast by Application (2024-2034)
6 North America
6.1 North America Bovine Vaccines Sales by Company
6.1.1 North America Bovine Vaccines Revenue by Company (2018-2024)
6.1.2 North America Bovine Vaccines Sales Quantity by Company (2018-2024)
6.2 North America Bovine Vaccines Market Size by Type
6.2.1 North America Bovine Vaccines Sales Quantity by Type (2018-2034)
6.2.2 North America Bovine Vaccines Revenue by Type (2018-2034)
6.3 North America Bovine Vaccines Market Size by Application
6.3.1 North America Bovine Vaccines Sales Quantity by Application (2018-2034)
6.3.2 North America Bovine Vaccines Revenue by Application (2018-2034)
6.4 North America Bovine Vaccines Market Size by Country
6.4.1 North America Bovine Vaccines Revenue by Country: 2018 VS 2022 VS 2034
6.4.2 North America Bovine Vaccines Revenue by Country (2018-2034)
6.4.3 North America Bovine Vaccines Sales Quantity by Country (2018-2034)
6.4.4 the United States
6.4.5 Canada
7 Europe
7.1 Europe Bovine Vaccines Sales by Company
7.1.1 Europe Bovine Vaccines Sales Quantity by Company (2018-2024)
7.1.2 Europe Bovine Vaccines Revenue by Company (2018-2024)
7.2 Europe Bovine Vaccines Market Size by Type
7.2.1 Europe Bovine Vaccines Sales Quantity by Type (2018-2034)
7.2.2 Europe Bovine Vaccines Revenue by Type (2018-2034)
7.3 Europe Bovine Vaccines Market Size by Application
7.3.1 Europe Bovine Vaccines Sales Quantity by Application (2018-2034)
7.3.2 Europe Bovine Vaccines Revenue by Application (2018-2034)
7.4 Europe Bovine Vaccines Market Size by Country
7.4.1 Europe Bovine Vaccines Revenue by Country: 2018 VS 2022 VS 2034
7.4.2 Europe Bovine Vaccines Revenue by Country (2018-2034)
7.4.3 Europe Bovine Vaccines Sales Quantity by Country (2018-2034)
7.4.4 Germany
7.4.5 France
7.4.6 UK
7.4.7 Italy
7.4.8 Russia
8 China
8.1 China Bovine Vaccines Sales by Company
8.1.1 China Bovine Vaccines Sales Quantity by Company (2018-2024)
8.1.2 China Bovine Vaccines Revenue by Company (2018-2024)
8.2 China Bovine Vaccines Market Size by Type
8.2.1 China Bovine Vaccines Sales Quantity by Type (2018-2034)
8.2.2 China Bovine Vaccines Revenue by Type (2018-2034)
8.3 China Bovine Vaccines Market Size by Application
8.3.1 China Bovine Vaccines Sales Quantity by Application (2018-2034)
8.3.2 China Bovine Vaccines Revenue by Application (2018-2034)
9 APAC (excluding China)
9.1 APAC Bovine Vaccines Sales by Company
9.1.1 APAC Bovine Vaccines Sales Quantity by Company (2018-2024)
9.1.2 APAC Bovine Vaccines Revenue by Company (2018-2024)
9.2 APAC Bovine Vaccines Market Size by Type
9.2.1 APAC Bovine Vaccines Sales Quantity by Type (2018-2034)
9.2.2 APAC Bovine Vaccines Revenue by Type (2018-2034)
9.3 APAC Bovine Vaccines Market Size by Application
9.3.1 APAC Bovine Vaccines Sales Quantity by Application (2018-2034)
9.3.2 APAC Bovine Vaccines Revenue by Application (2018-2034)
9.4 APAC Bovine Vaccines Market Size by Region
9.4.1 APAC Bovine Vaccines Revenue by Region: 2018 VS 2022 VS 2034
9.4.2 APAC Bovine Vaccines Revenue by Region (2018-2034)
9.4.3 APAC Bovine Vaccines Sales Quantity by Region (2018-2034)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Bovine Vaccines Sales by Company
10.1.1 Middle East, Africa and Latin America Bovine Vaccines Sales Quantity by Company (2018-2024)
10.1.2 Middle East, Africa and Latin America Bovine Vaccines Revenue by Company (2018-2024)
10.2 Middle East, Africa and Latin America Bovine Vaccines Market Size by Type
10.2.1 Middle East, Africa and Latin America Bovine Vaccines Sales Quantity by Type (2018-2034)
10.2.2 Middle East, Africa and Latin America Bovine Vaccines Revenue by Type (2018-2034)
10.3 Middle East, Africa and Latin America Bovine Vaccines Market Size by Application
10.3.1 Middle East, Africa and Latin America Bovine Vaccines Sales Quantity by Application (2018-2034)
10.3.2 Middle East, Africa and Latin America Bovine Vaccines Revenue by Application (2018-2034)
10.4 Middle East, Africa and Latin America Bovine Vaccines Market Size by Country
10.4.1 Middle East, Africa and Latin America Bovine Vaccines Revenue by Country: 2018 VS 2022 VS 2034
10.4.2 Middle East, Africa and Latin America Bovine Vaccines Revenue by Country (2018-2034)
10.4.3 Middle East, Africa and Latin America Bovine Vaccines Sales Quantity by Country (2018-2034)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Israel
10.4.8 GCC Countries
11 Company Profiles
11.1 Jinyu Group
11.1.1 Jinyu Group Company Information
11.1.2 Jinyu Group Overview
11.1.3 Jinyu Group Bovine Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.1.4 Jinyu Group Bovine Vaccines Products and Services
11.1.5 Jinyu Group Bovine Vaccines SWOT Analysis
11.1.6 Jinyu Group Recent Developments
11.2 Cavet Bio
11.2.1 Cavet Bio Company Information
11.2.2 Cavet Bio Overview
11.2.3 Cavet Bio Bovine Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.2.4 Cavet Bio Bovine Vaccines Products and Services
11.2.5 Cavet Bio Bovine Vaccines SWOT Analysis
11.2.6 Cavet Bio Recent Developments
11.3 CAHIC
11.3.1 CAHIC Company Information
11.3.2 CAHIC Overview
11.3.3 CAHIC Bovine Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.3.4 CAHIC Bovine Vaccines Products and Services
11.3.5 CAHIC Bovine Vaccines SWOT Analysis
11.3.6 CAHIC Recent Developments
11.4 Tecon Group
11.4.1 Tecon Group Company Information
11.4.2 Tecon Group Overview
11.4.3 Tecon Group Bovine Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.4.4 Tecon Group Bovine Vaccines Products and Services
11.4.5 Tecon Group Bovine Vaccines SWOT Analysis
11.4.6 Tecon Group Recent Developments
11.5 Shen Lian
11.5.1 Shen Lian Company Information
11.5.2 Shen Lian Overview
11.5.3 Shen Lian Bovine Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.5.4 Shen Lian Bovine Vaccines Products and Services
11.5.5 Shen Lian Bovine Vaccines SWOT Analysis
11.5.6 Shen Lian Recent Developments
11.6 Biogenesis Bagó
11.6.1 Biogenesis Bagó Company Information
11.6.2 Biogenesis Bagó Overview
11.6.3 Biogenesis Bagó Bovine Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.6.4 Biogenesis Bagó Bovine Vaccines Products and Services
11.6.5 Biogenesis Bagó Bovine Vaccines SWOT Analysis
11.6.6 Biogenesis Bagó Recent Developments
11.7 BIGVET Biotech
11.7.1 BIGVET Biotech Company Information
11.7.2 BIGVET Biotech Overview
11.7.3 BIGVET Biotech Bovine Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.7.4 BIGVET Biotech Bovine Vaccines Products and Services
11.7.5 BIGVET Biotech Bovine Vaccines SWOT Analysis
11.7.6 BIGVET Biotech Recent Developments
11.8 Indian Immunologicals
11.8.1 Indian Immunologicals Company Information
11.8.2 Indian Immunologicals Overview
11.8.3 Indian Immunologicals Bovine Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.8.4 Indian Immunologicals Bovine Vaccines Products and Services
11.8.5 Indian Immunologicals Bovine Vaccines SWOT Analysis
11.8.6 Indian Immunologicals Recent Developments
11.9 Boehringer Ingelheim
11.9.1 Boehringer Ingelheim Company Information
11.9.2 Boehringer Ingelheim Overview
11.9.3 Boehringer Ingelheim Bovine Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.9.4 Boehringer Ingelheim Bovine Vaccines Products and Services
11.9.5 Boehringer Ingelheim Bovine Vaccines SWOT Analysis
11.9.6 Boehringer Ingelheim Recent Developments
11.10 MSD Animal Health
11.10.1 MSD Animal Health Company Information
11.10.2 MSD Animal Health Overview
11.10.3 MSD Animal Health Bovine Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.10.4 MSD Animal Health Bovine Vaccines Products and Services
11.10.5 MSD Animal Health Bovine Vaccines SWOT Analysis
11.10.6 MSD Animal Health Recent Developments
11.11 CEVA
11.11.1 CEVA Company Information
11.11.2 CEVA Overview
11.11.3 CEVA Bovine Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.11.4 CEVA Bovine Vaccines Products and Services
11.11.5 CEVA Recent Developments
11.12 Bayer HealthCare
11.12.1 Bayer HealthCare Company Information
11.12.2 Bayer HealthCare Overview
11.12.3 Bayer HealthCare Bovine Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.12.4 Bayer HealthCare Bovine Vaccines Products and Services
11.12.5 Bayer HealthCare Recent Developments
11.13 VECOL
11.13.1 VECOL Company Information
11.13.2 VECOL Overview
11.13.3 VECOL Bovine Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.13.4 VECOL Bovine Vaccines Products and Services
11.13.5 VECOL Recent Developments
11.14 Sanofi (Merial)
11.14.1 Sanofi (Merial) Company Information
11.14.2 Sanofi (Merial) Overview
11.14.3 Sanofi (Merial) Bovine Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.14.4 Sanofi (Merial) Bovine Vaccines Products and Services
11.14.5 Sanofi (Merial) Recent Developments
11.15 Brilliant Bio Pharma
11.15.1 Brilliant Bio Pharma Company Information
11.15.2 Brilliant Bio Pharma Overview
11.15.3 Brilliant Bio Pharma Bovine Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.15.4 Brilliant Bio Pharma Bovine Vaccines Products and Services
11.15.5 Brilliant Bio Pharma Recent Developments
11.16 VETAL
11.16.1 VETAL Company Information
11.16.2 VETAL Overview
11.16.3 VETAL Bovine Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.16.4 VETAL Bovine Vaccines Products and Services
11.16.5 VETAL Recent Developments
11.17 BVI
11.17.1 BVI Company Information
11.17.2 BVI Overview
11.17.3 BVI Bovine Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.17.4 BVI Bovine Vaccines Products and Services
11.17.5 BVI Recent Developments
11.18 LIMOR
11.18.1 LIMOR Company Information
11.18.2 LIMOR Overview
11.18.3 LIMOR Bovine Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.18.4 LIMOR Bovine Vaccines Products and Services
11.18.5 LIMOR Recent Developments
11.19 ME VAC
11.19.1 ME VAC Company Information
11.19.2 ME VAC Overview
11.19.3 ME VAC Bovine Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.19.4 ME VAC Bovine Vaccines Products and Services
11.19.5 ME VAC Recent Developments
11.20 Agrovet
11.20.1 Agrovet Company Information
11.20.2 Agrovet Overview
11.20.3 Agrovet Bovine Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.20.4 Agrovet Bovine Vaccines Products and Services
11.20.5 Agrovet Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Bovine Vaccines Value Chain Analysis
12.2 Bovine Vaccines Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Bovine Vaccines Production Mode & Process
12.4 Bovine Vaccines Sales and Marketing
12.4.1 Bovine Vaccines Sales Channels
12.4.2 Bovine Vaccines Distributors
12.5 Bovine Vaccines Customers
13 Market Dynamics
13.1 Bovine Vaccines Industry Trends
13.2 Bovine Vaccines Market Drivers
13.3 Bovine Vaccines Market Challenges
13.4 Bovine Vaccines Market Restraints
14 Key Findings
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Bovine Vaccines Market Size Growth Rate (CAGR) by Type, 2018 VS 2022 VS 2034 (US$ Million)
Table 2. Major Manufacturers of Anti Rinderpest Serum
Table 3. Major Manufacturers of FMD Vaccine
Table 4. Major Manufacturers of Other
Table 5. Global Bovine Vaccines Market Size Growth Rate (CAGR) by Application, 2018 VS 2022 VS 2034 (US$ Million)
Table 6. Global Bovine Vaccines Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 7. Global Bovine Vaccines Revenue by Region (2018-2024) & (US$ Million)
Table 8. Global Bovine Vaccines Revenue Market Share by Region (2018-2024)
Table 9. Global Bovine Vaccines Revenue by Region (2024-2034) & (US$ Million)
Table 10. Global Bovine Vaccines Revenue Market Share by Region (2024-2034)
Table 11. Global Bovine Vaccines Sales Quantity by Region: 2018 VS 2022 VS 2034 (K Units)
Table 12. Global Bovine Vaccines Sales by Region (2018-2024) & (K Units)
Table 13. Global Bovine Vaccines Sales Market Share by Region (2018-2024)
Table 14. Global Bovine Vaccines Sales by Region (2024-2034) & (K Units)
Table 15. Global Bovine Vaccines Sales Market Share by Region (2024-2034)
Table 16. Global Bovine Vaccines Sales Quantity by Manufacturers (2018-2024) & (K Units)
Table 17. Global Bovine Vaccines Sales Quantity Share by Manufacturers (2018-2024)
Table 18. Global Bovine Vaccines Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 19. Global Bovine Vaccines Revenue Share by Manufacturers (2018-2024)
Table 20. Global Bovine Vaccines Price by Manufacturers 2018-2024 (USD/Unit)
Table 21. Global Key Players of Bovine Vaccines, Industry Ranking, 2021 VS 2022
Table 22. Global Bovine Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 23. Global Bovine Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bovine Vaccines as of 2022)
Table 24. Global Key Manufacturers of Bovine Vaccines, Manufacturing Base Distribution and Headquarters
Table 25. Global Key Manufacturers of Bovine Vaccines, Product Offered and Application
Table 26. Global Key Manufacturers of Bovine Vaccines, Date of Enter into This Industry
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Bovine Vaccines Sales Quantity by Type (2018-2024) & (K Units)
Table 29. Global Bovine Vaccines Sales Quantity by Type (2024-2034) & (K Units)
Table 30. Global Bovine Vaccines Sales Quantity Share by Type (2018-2024)
Table 31. Global Bovine Vaccines Sales Quantity Share by Type (2024-2034)
Table 32. Global Bovine Vaccines Revenue by Type (2018-2024) & (US$ Million)
Table 33. Global Bovine Vaccines Revenue by Type (2024-2034) & (US$ Million)
Table 34. Global Bovine Vaccines Revenue Share by Type (2018-2024)
Table 35. Global Bovine Vaccines Revenue Share by Type (2024-2034)
Table 36. Bovine Vaccines Price by Type (2018-2024) & (USD/Unit)
Table 37. Global Bovine Vaccines Price Forecast by Type (2024-2034) & (USD/Unit)
Table 38. Global Bovine Vaccines Sales Quantity by Application (2018-2024) & (K Units)
Table 39. Global Bovine Vaccines Sales Quantity by Application (2024-2034) & (K Units)
Table 40. Global Bovine Vaccines Sales Quantity Share by Application (2018-2024)
Table 41. Global Bovine Vaccines Sales Quantity Share by Application (2024-2034)
Table 42. Global Bovine Vaccines Revenue by Application (2018-2024) & (US$ Million)
Table 43. Global Bovine Vaccines Revenue by Application (2024-2034) & (US$ Million)
Table 44. Global Bovine Vaccines Revenue Share by Application (2018-2024)
Table 45. Global Bovine Vaccines Revenue Share by Application (2024-2034)
Table 46. Bovine Vaccines Price by Application (2018-2024) & (USD/Unit)
Table 47. Global Bovine Vaccines Price Forecast by Application (2024-2034) & (USD/Unit)
Table 48. North America Bovine Vaccines Revenue by Company (2018-2024) & (US$ Million)
Table 49. North America Bovine Vaccines Sales Quantity by Company (2018-2024) & (K Units)
Table 50. North America Bovine Vaccines Sales Quantity by Type (2018-2024) & (K Units)
Table 51. North America Bovine Vaccines Sales Quantity by Type (2024-2034) & (K Units)
Table 52. North America Bovine Vaccines Revenue by Type (2018-2024) & (US$ Million)
Table 53. North America Bovine Vaccines Revenue by Type (2024-2034) & (US$ Million)
Table 54. North America Bovine Vaccines Sales Quantity by Application (2018-2024) & (K Units)
Table 55. North America Bovine Vaccines Sales Quantity by Application (2024-2034) & (K Units)
Table 56. North America Bovine Vaccines Revenue by Application (2018-2024) & (US$ Million)
Table 57. North America Bovine Vaccines Revenue by Application (2024-2034) & (US$ Million)
Table 58. North America Bovine Vaccines Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 59. North America Bovine Vaccines Revenue by Country (2018-2024) & (US$ Million)
Table 60. North America Bovine Vaccines Revenue by Country (2024-2034) & (US$ Million)
Table 61. North America Bovine Vaccines Sales Quantity by Country (2018-2024) & (K Units)
Table 62. North America Bovine Vaccines Sales Quantity by Country (2024-2034) & (K Units)
Table 63. Europe Bovine Vaccines Sales Quantity by Company (2018-2024) & (K Units)
Table 64. Europe Bovine Vaccines Revenue by Company (2018-2024) & (US$ Million)
Table 65. Europe Bovine Vaccines Sales Quantity by Type (2018-2024) & (K Units)
Table 66. Europe Bovine Vaccines Sales Quantity by Type (2024-2034) & (K Units)
Table 67. Europe Bovine Vaccines Revenue by Type (2018-2024) & (US$ Million)
Table 68. Europe Bovine Vaccines Revenue by Type (2024-2034) & (US$ Million)
Table 69. Europe Bovine Vaccines Sales Quantity by Application (2018-2024) & (K Units)
Table 70. Europe Bovine Vaccines Sales Quantity by Application (2024-2034) & (K Units)
Table 71. Europe Bovine Vaccines Revenue by Application (2018-2024) & (US$ Million)
Table 72. Europe Bovine Vaccines Revenue by Application (2024-2034) & (US$ Million)
Table 73. Europe Bovine Vaccines Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 74. Europe Bovine Vaccines Revenue by Country (2018-2024) & (US$ Million)
Table 75. Europe Bovine Vaccines Revenue by Country (2024-2034) & (US$ Million)
Table 76. Europe Bovine Vaccines Sales Quantity by Country (2018-2024) & (K Units)
Table 77. Europe Bovine Vaccines Sales Quantity by Country (2024-2034) & (K Units)
Table 78. China Bovine Vaccines Sales Quantity by Company (2018-2024) & (K Units)
Table 79. China Bovine Vaccines Revenue by Company (2018-2024) & (US$ Million)
Table 80. China Bovine Vaccines Sales Quantity by Type (2018-2024) & (K Units)
Table 81. China Bovine Vaccines Sales Quantity by Type (2024-2034) & (K Units)
Table 82. China Bovine Vaccines Revenue by Type (2018-2024) & (US$ Million)
Table 83. China Bovine Vaccines Revenue by Type (2024-2034) & (US$ Million)
Table 84. China Bovine Vaccines Sales Quantity by Application (2018-2024) & (K Units)
Table 85. China Bovine Vaccines Sales Quantity by Application (2024-2034) & (K Units)
Table 86. China Bovine Vaccines Revenue by Application (2018-2024) & (US$ Million)
Table 87. China Bovine Vaccines Revenue by Application (2024-2034) & (US$ Million)
Table 88. APAC Bovine Vaccines Sales Quantity by Company (2018-2024) & (K Units)
Table 89. APAC Bovine Vaccines Revenue by Company (2018-2024) & (US$ Million)
Table 90. APAC Bovine Vaccines Sales Quantity by Type (2018-2024) & (K Units)
Table 91. APAC Bovine Vaccines Sales Quantity by Type (2024-2034) & (K Units)
Table 92. APAC Bovine Vaccines Revenue by Type (2018-2024) & (US$ Million)
Table 93. APAC Bovine Vaccines Revenue by Type (2024-2034) & (US$ Million)
Table 94. APAC Bovine Vaccines Sales Quantity by Application (2018-2024) & (K Units)
Table 95. APAC Bovine Vaccines Sales Quantity by Application (2024-2034) & (K Units)
Table 96. APAC Bovine Vaccines Revenue by Application (2018-2024) & (US$ Million)
Table 97. APAC Bovine Vaccines Revenue by Application (2024-2034) & (US$ Million)
Table 98. APAC Bovine Vaccines Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 99. APAC Bovine Vaccines Revenue by Region (2018-2024) & (US$ Million)
Table 100. APAC Bovine Vaccines Revenue by Region (2024-2034) & (US$ Million)
Table 101. APAC Bovine Vaccines Sales Quantity by Region (2018-2024) & (K Units)
Table 102. APAC Bovine Vaccines Sales Quantity by Region (2024-2034) & (K Units)
Table 103. Middle East, Africa and Latin America Bovine Vaccines Sales Quantity by Company (2018-2024) & (K Units)
Table 104. Middle East, Africa and Latin America Bovine Vaccines Revenue by Company (2018-2024) & (US$ Million)
Table 105. Middle East, Africa and Latin America Bovine Vaccines Sales Quantity by Type (2018-2024) & (K Units)
Table 106. Middle East, Africa and Latin America Bovine Vaccines Sales Quantity by Type (2024-2034) & (K Units)
Table 107. Middle East, Africa and Latin America Bovine Vaccines Revenue by Type (2018-2024) & (US$ Million)
Table 108. Middle East, Africa and Latin America Bovine Vaccines Revenue by Type (2024-2034) & (US$ Million)
Table 109. Middle East, Africa and Latin America Bovine Vaccines Sales Quantity by Application (2018-2024) & (K Units)
Table 110. Middle East, Africa and Latin America Bovine Vaccines Sales Quantity by Application (2024-2034) & (K Units)
Table 111. Middle East, Africa and Latin America Bovine Vaccines Revenue by Application (2018-2024) & (US$ Million)
Table 112. Middle East, Africa and Latin America Bovine Vaccines Revenue by Application (2024-2034) & (US$ Million)
Table 113. Middle East, Africa and Latin America Bovine Vaccines Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 114. Middle East, Africa and Latin America Bovine Vaccines Revenue by Country (2018-2024) & (US$ Million)
Table 115. Middle East, Africa and Latin America Bovine Vaccines Revenue by Country (2024-2034) & (US$ Million)
Table 116. Middle East, Africa and Latin America Bovine Vaccines Sales Quantity by Country (2018-2024) & (K Units)
Table 117. Middle East, Africa and Latin America Bovine Vaccines Sales Quantity by Country (2024-2034) & (K Units)
Table 118. Jinyu Group Company Information
Table 119. Jinyu Group Description and Overview
Table 120. Jinyu Group Bovine Vaccines Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 121. Jinyu Group Bovine Vaccines Product and Services
Table 122. Jinyu Group Bovine Vaccines SWOT Analysis
Table 123. Jinyu Group Recent Developments
Table 124. Cavet Bio Company Information
Table 125. Cavet Bio Description and Overview
Table 126. Cavet Bio Bovine Vaccines Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 127. Cavet Bio Bovine Vaccines Product and Services
Table 128. Cavet Bio Bovine Vaccines SWOT Analysis
Table 129. Cavet Bio Recent Developments
Table 130. CAHIC Company Information
Table 131. CAHIC Description and Overview
Table 132. CAHIC Bovine Vaccines Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 133. CAHIC Bovine Vaccines Product and Services
Table 134. CAHIC Bovine Vaccines SWOT Analysis
Table 135. CAHIC Recent Developments
Table 136. Tecon Group Company Information
Table 137. Tecon Group Description and Overview
Table 138. Tecon Group Bovine Vaccines Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 139. Tecon Group Bovine Vaccines Product and Services
Table 140. Tecon Group Bovine Vaccines SWOT Analysis
Table 141. Tecon Group Recent Developments
Table 142. Shen Lian Company Information
Table 143. Shen Lian Description and Overview
Table 144. Shen Lian Bovine Vaccines Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 145. Shen Lian Bovine Vaccines Product and Services
Table 146. Shen Lian Bovine Vaccines SWOT Analysis
Table 147. Shen Lian Recent Developments
Table 148. Biogenesis Bagó Company Information
Table 149. Biogenesis Bagó Description and Overview
Table 150. Biogenesis Bagó Bovine Vaccines Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 151. Biogenesis Bagó Bovine Vaccines Product and Services
Table 152. Biogenesis Bagó Bovine Vaccines SWOT Analysis
Table 153. Biogenesis Bagó Recent Developments
Table 154. BIGVET Biotech Company Information
Table 155. BIGVET Biotech Description and Overview
Table 156. BIGVET Biotech Bovine Vaccines Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 157. BIGVET Biotech Bovine Vaccines Product and Services
Table 158. BIGVET Biotech Bovine Vaccines SWOT Analysis
Table 159. BIGVET Biotech Recent Developments
Table 160. Indian Immunologicals Company Information
Table 161. Indian Immunologicals Description and Overview
Table 162. Indian Immunologicals Bovine Vaccines Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 163. Indian Immunologicals Bovine Vaccines Product and Services
Table 164. Indian Immunologicals Bovine Vaccines SWOT Analysis
Table 165. Indian Immunologicals Recent Developments
Table 166. Boehringer Ingelheim Company Information
Table 167. Boehringer Ingelheim Description and Overview
Table 168. Boehringer Ingelheim Bovine Vaccines Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 169. Boehringer Ingelheim Bovine Vaccines Product and Services
Table 170. Boehringer Ingelheim Bovine Vaccines SWOT Analysis
Table 171. Boehringer Ingelheim Recent Developments
Table 172. MSD Animal Health Company Information
Table 173. MSD Animal Health Description and Overview
Table 174. MSD Animal Health Bovine Vaccines Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 175. MSD Animal Health Bovine Vaccines Product and Services
Table 176. MSD Animal Health Bovine Vaccines SWOT Analysis
Table 177. MSD Animal Health Recent Developments
Table 178. CEVA Company Information
Table 179. CEVA Description and Overview
Table 180. CEVA Bovine Vaccines Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 181. CEVA Bovine Vaccines Product and Services
Table 182. CEVA Recent Developments
Table 183. Bayer HealthCare Company Information
Table 184. Bayer HealthCare Description and Overview
Table 185. Bayer HealthCare Bovine Vaccines Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 186. Bayer HealthCare Bovine Vaccines Product and Services
Table 187. Bayer HealthCare Recent Developments
Table 188. VECOL Company Information
Table 189. VECOL Description and Overview
Table 190. VECOL Bovine Vaccines Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 191. VECOL Bovine Vaccines Product and Services
Table 192. VECOL Recent Developments
Table 193. Sanofi (Merial) Company Information
Table 194. Sanofi (Merial) Description and Overview
Table 195. Sanofi (Merial) Bovine Vaccines Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 196. Sanofi (Merial) Bovine Vaccines Product and Services
Table 197. Sanofi (Merial) Recent Developments
Table 198. Brilliant Bio Pharma Company Information
Table 199. Brilliant Bio Pharma Description and Overview
Table 200. Brilliant Bio Pharma Bovine Vaccines Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 201. Brilliant Bio Pharma Bovine Vaccines Product and Services
Table 202. Brilliant Bio Pharma Recent Developments
Table 203. VETAL Company Information
Table 204. VETAL Description and Overview
Table 205. VETAL Bovine Vaccines Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 206. VETAL Bovine Vaccines Product and Services
Table 207. VETAL Recent Developments
Table 208. BVI Company Information
Table 209. BVI Description and Overview
Table 210. BVI Bovine Vaccines Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 211. BVI Bovine Vaccines Product and Services
Table 212. BVI Recent Developments
Table 213. LIMOR Company Information
Table 214. LIMOR Description and Overview
Table 215. LIMOR Bovine Vaccines Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 216. LIMOR Bovine Vaccines Product and Services
Table 217. LIMOR Recent Developments
Table 218. ME VAC Company Information
Table 219. ME VAC Description and Overview
Table 220. ME VAC Bovine Vaccines Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 221. ME VAC Bovine Vaccines Product and Services
Table 222. ME VAC Recent Developments
Table 223. Agrovet Company Information
Table 224. Agrovet Description and Overview
Table 225. Agrovet Bovine Vaccines Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 226. Agrovet Bovine Vaccines Product and Services
Table 227. Agrovet Recent Developments
Table 228. Key Raw Materials Lists
Table 229. Raw Materials Key Suppliers Lists
Table 230. Bovine Vaccines Distributors List
Table 231. Bovine Vaccines Customers List
Table 232. Bovine Vaccines Market Trends
Table 233. Bovine Vaccines Market Drivers
Table 234. Bovine Vaccines Market Challenges
Table 235. Bovine Vaccines Market Restraints
Table 236. Research Programs/Design for This Report
Table 237. Key Data Information from Secondary Sources
Table 238. Key Data Information from Primary Sources
List of Figures
Figure 1. Bovine Vaccines Product Picture
Figure 2. Global Bovine Vaccines Market Size Growth Rate by Type, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Bovine Vaccines Market Share by Type in 2022 & 2034
Figure 4. Anti Rinderpest Serum Product Picture
Figure 5. FMD Vaccine Product Picture
Figure 6. Other Product Picture
Figure 7. Global Bovine Vaccines Market Size Growth Rate by Application, 2018 VS 2022 VS 2034 (US$ Million)
Figure 8. Global Bovine Vaccines Market Share by Application in 2022 & 2034
Figure 9. Farm
Figure 10. Government
Figure 11. Bovine Vaccines Report Years Considered
Figure 12. Global Bovine Vaccines Revenue, (US$ Million), 2018 VS 2022 VS 2034
Figure 13. Global Bovine Vaccines Revenue 2018-2034 (US$ Million)
Figure 14. Global Bovine Vaccines Revenue Market Share by Region in Percentage: 2022 Versus 2034
Figure 15. Global Bovine Vaccines Sales Quantity 2018-2034 (K Units)
Figure 16. Global Bovine Vaccines Sales Quantity Market Share by Region (2018-2024)
Figure 17. Global Bovine Vaccines Sales Quantity Market Share by Region (2024-2034)
Figure 18. North America Bovine Vaccines Sales Quantity YoY (2018-2034) & (K Units)
Figure 19. North America Bovine Vaccines Revenue YoY (2018-2034) & (US$ Million)
Figure 20. Europe Bovine Vaccines Sales Quantity YoY (2018-2034) & (K Units)
Figure 21. Europe Bovine Vaccines Revenue YoY (2018-2034) & (US$ Million)
Figure 22. China Bovine Vaccines Sales Quantity YoY (2018-2034) & (K Units)
Figure 23. China Bovine Vaccines Revenue YoY (2018-2034) & (US$ Million)
Figure 24. APAC Bovine Vaccines Sales Quantity YoY (2018-2034) & (K Units)
Figure 25. APAC Bovine Vaccines Revenue YoY (2018-2034) & (US$ Million)
Figure 26. Middle East, Africa and Latin America Bovine Vaccines Sales Quantity YoY (2018-2034) & (K Units)
Figure 27. Middle East, Africa and Latin America Bovine Vaccines Revenue YoY (2018-2034) & (US$ Million)
Figure 28. The Top 10 and Top 5 Players Market Share by Bovine Vaccines Sales Quantity in 2022
Figure 29. The Top 10 and Top 5 Players Market Share by Bovine Vaccines Revenue in 2022
Figure 30. Bovine Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 31. Global Bovine Vaccines Sales Quantity Market Share by Type (2018-2034)
Figure 32. Global Bovine Vaccines Revenue Market Share by Type (2018-2034)
Figure 33. Global Bovine Vaccines Sales Quantity Market Share by Application (2018-2034)
Figure 34. Global Bovine Vaccines Revenue Market Share by Application (2018-2034)
Figure 35. North America Bovine Vaccines Revenue Market Share by Company in 2022
Figure 36. North America Bovine Vaccines Sales Quantity Market Share by Company in 2022
Figure 37. North America Bovine Vaccines Sales Quantity Market Share by Type (2018-2034)
Figure 38. North America Bovine Vaccines Revenue Market Share by Type (2018-2034)
Figure 39. North America Bovine Vaccines Sales Quantity Market Share by Application (2018-2034)
Figure 40. North America Bovine Vaccines Revenue Market Share by Application (2018-2034)
Figure 41. North America Bovine Vaccines Revenue Share by Country (2018-2034)
Figure 42. North America Bovine Vaccines Sales Quantity Share by Country (2018-2034)
Figure 43. the United States Bovine Vaccines Revenue (2018-2034) & (US$ Million)
Figure 44. Canada Bovine Vaccines Revenue (2018-2034) & (US$ Million)
Figure 45. Europe Bovine Vaccines Sales Quantity Market Share by Company in 2022
Figure 46. Europe Bovine Vaccines Revenue Market Share by Company in 2022
Figure 47. Europe Bovine Vaccines Sales Quantity Market Share by Type (2018-2034)
Figure 48. Europe Bovine Vaccines Revenue Market Share by Type (2018-2034)
Figure 49. Europe Bovine Vaccines Sales Quantity Market Share by Application (2018-2034)
Figure 50. Europe Bovine Vaccines Revenue Market Share by Application (2018-2034)
Figure 51. Europe Bovine Vaccines Revenue Share by Country (2018-2034)
Figure 52. Europe Bovine Vaccines Sales Quantity Share by Country (2018-2034)
Figure 53. Germany Bovine Vaccines Revenue (2018-2034) & (US$ Million)
Figure 54. France Bovine Vaccines Revenue (2018-2034) & (US$ Million)
Figure 55. UK Bovine Vaccines Revenue (2018-2034) & (US$ Million)
Figure 56. Italy Bovine Vaccines Revenue (2018-2034) & (US$ Million)
Figure 57. Russia Bovine Vaccines Revenue (2018-2034) & (US$ Million)
Figure 58. China Bovine Vaccines Sales Quantity Market Share by Company in 2022
Figure 59. China Bovine Vaccines Revenue Market Share by Company in 2022
Figure 60. China Bovine Vaccines Sales Quantity Market Share by Type (2018-2034)
Figure 61. China Bovine Vaccines Revenue Market Share by Type (2018-2034)
Figure 62. China Bovine Vaccines Sales Quantity Market Share by Application (2018-2034)
Figure 63. China Bovine Vaccines Revenue Market Share by Application (2018-2034)
Figure 64. APAC Bovine Vaccines Sales Quantity Market Share by Company in 2022
Figure 65. APAC Bovine Vaccines Revenue Market Share by Company in 2022
Figure 66. APAC Bovine Vaccines Sales Quantity Market Share by Type (2018-2034)
Figure 67. APAC Bovine Vaccines Revenue Market Share by Type (2018-2034)
Figure 68. APAC Bovine Vaccines Sales Quantity Market Share by Application (2018-2034)
Figure 69. APAC Bovine Vaccines Revenue Market Share by Application (2018-2034)
Figure 70. APAC Bovine Vaccines Revenue Share by Region (2018-2034)
Figure 71. APAC Bovine Vaccines Sales Quantity Share by Region (2018-2034)
Figure 72. Japan Bovine Vaccines Revenue (2018-2034) & (US$ Million)
Figure 73. South Korea Bovine Vaccines Revenue (2018-2034) & (US$ Million)
Figure 74. China Taiwan Bovine Vaccines Revenue (2018-2034) & (US$ Million)
Figure 75. Southeast Asia Bovine Vaccines Revenue (2018-2034) & (US$ Million)
Figure 76. India Bovine Vaccines Revenue (2018-2034) & (US$ Million)
Figure 77. Middle East, Africa and Latin America Bovine Vaccines Sales Quantity Market Share by Company in 2022
Figure 78. Middle East, Africa and Latin America Bovine Vaccines Revenue Market Share by Company in 2022
Figure 79. Middle East, Africa and Latin America Bovine Vaccines Sales Quantity Market Share by Type (2018-2034)
Figure 80. Middle East, Africa and Latin America Bovine Vaccines Revenue Market Share by Type (2018-2034)
Figure 81. Middle East, Africa and Latin America Bovine Vaccines Sales Quantity Market Share by Application (2018-2034)
Figure 82. Middle East, Africa and Latin America Bovine Vaccines Revenue Market Share by Application (2018-2034)
Figure 83. Middle East, Africa and Latin America Bovine Vaccines Sales Quantity Share by Country (2018-2034)
Figure 84. Middle East, Africa and Latin America Bovine Vaccines Revenue Share by Country (2018-2034)
Figure 85. Brazil Bovine Vaccines Revenue (2018-2034) & (US$ Million)
Figure 86. Mexico Bovine Vaccines Revenue (2018-2034) & (US$ Million)
Figure 87. Turkey Bovine Vaccines Revenue (2018-2034) & (US$ Million)
Figure 88. Israel Bovine Vaccines Revenue (2018-2034) & (US$ Million)
Figure 89. GCC Countries Bovine Vaccines Revenue (2018-2034) & (US$ Million)
Figure 90. Bovine Vaccines Value Chain
Figure 91. Bovine Vaccines Production Process
Figure 92. Channels of Distribution (Direct Vs Distribution)
Figure 93. Distributors Profiles
Figure 94. Bottom-up and Top-down Approaches for This Report
Figure 95. Data Triangulation
Figure 96. Key Executives Interviewed